Heterozygosity for Hypoxia Inducible Factor 1α Decreases the Incidence of Thymic Lymphomas in a p53 Mutant Mouse Model

被引:31
作者
Bertout, Jessica A. [2 ]
Patel, Shetal A.
Fryer, Benjamin H.
Durham, Amy C. [2 ]
Covello, Kelly L.
Olive, Kenneth P.
Goldschmidt, Michael H. [2 ]
Simon, M. Celeste [1 ]
机构
[1] Univ Penn, Sch Med, Howard Hughes Med Inst, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA
关键词
RENAL-CELL CARCINOMA; TUMOR-SUPPRESSOR; HIF-2-ALPHA PROMOTES; C-MYC; CANCER; MICE; LEUKEMIA; NOTCH1; HIF-1-ALPHA; EXPRESSION;
D O I
10.1158/0008-5472.CAN-08-4223
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hypoxia inducible factors (HIF) are critical mediators of the cellular response to decreased oxygen tension and arc over-expressed in a number of tumors. Although HIF1 alpha and HIF2 alpha share a high degree of sequence homology, recent work has shown that the two alpha subunits can have contrasting and tissue-specific effects on tumor growth. To directly compare the role of each HIF alpha subunit in spontaneous tumorigenesis, we bred a mouse model of expanded HIF2 alpha expression and Hif1 alpha(+/-) mice to homozygotes for the R270H mutation in p53. Here, we report that p53(R270H/R270H) mice, which have not been previously described, develop a unique tumor spectrum relative to p53(p270H/-) mice, including a high incidence of thymic lymphomas. Heterozygosity for Hif1 alpha significantly reduced the incidence of thymic lymphomas observed in this model. Moreover, reduced Hif1 alpha levels correlated with decreased stabilization of activated Notch1 and expression of the Notch target genes, Dtx1 and Nrarp. These observations uncover a novel role for HIF1 alpha in Notch pathway activation during T-cell lymphomagenesis. [Cancer Res 2009;69(7):3213-20]
引用
收藏
页码:3213 / 3220
页数:8
相关论文
共 40 条
[1]   Genetic evidence for a tumor suppressor role of HIF-2α [J].
Acker, T ;
Diez-Juan, A ;
Aragones, J ;
Tjwa, M ;
Brusselmans, K ;
Moons, L ;
Fukumura, D ;
Moreno-Murciano, MP ;
Herbert, JM ;
Burger, A ;
Riedel, J ;
Elverl, G ;
Flamme, I ;
Maxwell, PH ;
Collen, D ;
Dewerchin, M ;
Jain, RK ;
Plate, KH ;
Carmeliet, P .
CANCER CELL, 2005, 8 (02) :131-141
[2]   Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by Notch1 [J].
Aster, JC ;
Xu, LW ;
Karnell, FG ;
Patriub, V ;
Pui, JC ;
Pear, WS .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (20) :7505-7515
[3]   Notch signaling in leukemia [J].
Aster, Jon C. ;
Pear, Warren S. ;
Blacklow, Stephen C. .
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2008, 3 :587-613
[4]   The role of p53 in tumour suppression: lessons from mouse models [J].
Attardi, LD ;
Jacks, T .
CELLULAR AND MOLECULAR LIFE SCIENCES, 1999, 55 (01) :48-63
[5]   Histone H2AX: A dosage-dependent suppressor of oncogenic translocations and tumors [J].
Bassing, CH ;
Suh, H ;
Ferguson, DO ;
Chua, KF ;
Manis, J ;
Eckersdorff, M ;
Gleason, M ;
Bronson, R ;
Lee, C ;
Alt, FW .
CELL, 2003, 114 (03) :359-370
[6]   Constitutive activation of NF-κB and T-cell leukemia/lymphoma in Notch3 transgenic mice [J].
Bellavia, D ;
Campese, AF ;
Alesse, E ;
Vacca, A ;
Felli, MP ;
Balestri, A ;
Stoppacciaro, A ;
Tiveron, C ;
Tatangelo, L ;
Giovarelli, M ;
Gaetano, C ;
Ruco, L ;
Hoffman, ES ;
Hayday, AC ;
Lendahl, U ;
Frati, L ;
Gulino, A ;
Screpanti, I .
EMBO JOURNAL, 2000, 19 (13) :3337-3348
[7]   HIF-2α regulates Oct-4:: effects of hypoxia on stem cell function, embryonic development, and tumor growth [J].
Covello, KL ;
Kehler, J ;
Yu, HW ;
Gordan, JD ;
Arsham, AM ;
Hu, CJ ;
Labosky, PA ;
Simon, MC ;
Keith, B .
GENES & DEVELOPMENT, 2006, 20 (05) :557-570
[8]   Targeted replacement of hypoxia-inducible factor-1α by a hypoxia-inducible factor-2α knock-in allele promotes tumor growth [J].
Covello, KL ;
Simon, MC ;
Keith, B .
CANCER RESEARCH, 2005, 65 (06) :2277-2286
[9]   Hypoxia and metabolism - Opinion - The interplay between MYC and HIF in cancer [J].
Dang, Chi V. ;
Kim, Jung-whan ;
Gao, Ping ;
Yustein, Jason .
NATURE REVIEWS CANCER, 2008, 8 (01) :51-56
[10]   HIF-dependent antitumorigenic effect of antioxidants in vivo [J].
Gao, Ping ;
Zhang, Huafeng ;
Dinavahi, Ramani ;
Li, Feng ;
Xiang, Yan ;
Raman, Venu ;
Bhujwalla, Zaver M. ;
Felsher, Dean W. ;
Cheng, Linzhao ;
Pevsner, Jonathan ;
Lee, Linda A. ;
Semenza, Gregg L. ;
Dang, Chi V. .
CANCER CELL, 2007, 12 (03) :230-238